At convEyXO, we’re dedicated to pioneering new treatments that benefit patients. Our pipeline represents our commitment to transforming patient care, with programs in discovery through to pre-clinical development. Join us as we work tirelessly to bring value to all our stakeholders.

We develop an exosome-based therapeutic portfolio (EVs) to cure degenerative diseases with their anti-inflammatory and regenerative properties, and enhanced by loaded cargo (miRNA), leveraging their cell-cell communication role